Alps Medical Breakthroughs ETF (SBIO)

$34.86 $-0.55 (-1.55%)

  • Last Price:
    $34.86
  • Previous Close:
    $35.41
  • Change:
    $-0.55 (-1.55%)
  • Open:
    $35.35
  • Volume:
    19,249
  • Day's Range:
    $34.81 - $35.60
  • Dividend Yield:
    1.66%
  • 52-week Range:
    $37.20 - $24.10
  • P-E:
    0
  • EPS:
    $0.00

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

It seems we can’t find what you’re looking for. Perhaps searching can help.